Table 2.
Variable | Total (n = 30) |
---|---|
Age at baseline | 76.6 (61-89) |
Clinical stage | |
T1c | 7 (23.3%) |
T2 | 17 (56.7%) |
T3 | 5 (16.7%) |
T4 | 1 (3.3%) |
PSA at baseline | 25.56 (6.58-98.4) |
Gleason score | |
6 | 4 (13.3%) |
7 | 9 (30.0%) |
8 | 9 (30.0%) |
9-10 | 8 (26.7%) |
Risk category (based on NCCN criteria) | |
High | 23 (76.6%) |
Very high | 7 (23.3%) |
Abbreviations: NCCN = National Comprehensive Cancer Network; PSA = prostate-specific antigen.